Somatostatin analog therapy effectiveness on the progression of polycystic kidney and liver disease: A systematic review and meta-analysis of randomized clinical trials.
<h4>Background</h4>Uncertainty underlies the effectiveness of somatostatin analogues for slowing the progression of polycystic kidney or liver disease.<h4>Methods</h4>Eligible studies included randomized controlled trials (RCTs) evaluating somatostatin analog as therapy for p...
Saved in:
| Main Authors: | Tatsuya Suwabe, Francisco J Barrera, Rene Rodriguez-Gutierrez, Yoshifumi Ubara, Marie C Hogan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2021-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0257606&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Brachial-ankle pulse wave velocity predicts liver volume in patients with autosomal dominant polycystic kidney disease
by: Wasako Tato, et al.
Published: (2025-01-01) -
Long-acting somatostatin analogue treatments in autosomal dominant polycystic kidney disease and polycystic liver disease: a systematic review and meta-analysis
by: Mark T Mills, et al.
Published: (2020-01-01) -
Dialysis-related amyloidosis: a review from case series
by: Yoshifumi Ubara, et al.
Published: (2025-02-01) -
Metastatic Insulinoma Managed with Radiolabeled Somatostatin Analog
by: Ricardo Costa, et al.
Published: (2013-01-01) -
Corrigendum: Estrogens modulate somatostatin receptors expression and synergize with the somatostatin analog pasireotide in prostate cells
by: Valentina Rossi, et al.
Published: (2024-12-01)